NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00338-9159-30 — Sodium chloride 0.9% IV bagAI (404 hospitals, 65,381–72,239 samples)
• NDC 76329-3352-01 — Sodium bicarbonate 8.4% IV solutionAI (1098 hospitals, 65,186–71,936 samples)
• NDC 54643-5649-01 — Multivitamin intravenous solutionAI (1334 hospitals, 68,648–71,546 samples)
• NDC 63323-0162-00 — Ketorolac pain medication injection, 30 mg/mLAI (576 hospitals, 62,699–71,456 samples)
• NDC 63323-0463-57 — Bupivacaine with epinephrine numbing injectionAI (525 hospitals, 68,556–71,220 samples)
• NDC 00338-0017-18 — Dextrose 5% intravenous solutionAI (392 hospitals, 69,210–71,109 samples)
• NDC 25021-0673-76 — Lidocaine 2% jelly tubeAI (950 hospitals, 68,687–70,946 samples)
• NDC 00641-0367-25 — Dexamethasone sodium phosphate injectionAI (835 hospitals, 57,146–70,853 samples)
• NDC 00065-0795-15 — Balanced salt solution for eye surgeryAI (1078 hospitals, 68,188–70,762 samples)
• NDC 00143-9250-01 — Rocuronium 10 mg/mL IV injection (muscle relaxant)AI (229 hospitals, 69,592–70,753 samples)
• NDC 00409-6648-02 — 50% dextrose injectionAI (757 hospitals, 68,613–70,737 samples)
• NDC 00944-2700-11 — Immune globulin (IgG) 10% injectionAI (339 hospitals, 70,579–70,723 samples)
• NDC 55150-0225-05 — Rocuronium 10 mg/mL injection solutionAI (487 hospitals, 67,930–70,576 samples)
• NDC 76329-3013-05 — Lidocaine 2% urethral/mucosal gel sprayAI (886 hospitals, 66,882–70,491 samples)
• NDC 00409-1749-29 — Marcaine with epinephrine, preservative-free 0.5% injectionAI (592 hospitals, 68,761–70,480 samples)
• NDC 55150-0172-30 — Bupivacaine 0.75% injection solutionAI (476 hospitals, 61,163–69,992 samples)
• NDC 70436-0126-34 — Low-osmolar iodinated contrast dye, per mLAI (50 hospitals, 69,372–69,885 samples)
• NDC 72266-0119-01 — Ketorolac 60 mg injection for muscleAI (311 hospitals, 67,824–69,660 samples)
• NDC 00378-6997-89 — Sodium chloride 3% nebulizer solutionAI (549 hospitals, 68,198–69,386 samples)
• NDC 55150-0163-30 — Lidocaine 1% injection solutionAI (696 hospitals, 63,212–69,350 samples)
• NDC 63323-0492-37 — Xylocaine 1% injectable solutionAI (742 hospitals, 58,700–69,167 samples)
• NDC 63323-0426-02 — Rocuronium injection (10 mg/mL)AI (305 hospitals, 66,977–69,119 samples)
• NDC 00409-7295-01 — Potassium phosphate injectionAI (818 hospitals, 67,038–68,991 samples)
• NDC 00143-9595-01 — Lidocaine 1% numbing injection, preservative-freeAI (379 hospitals, 62,505–68,895 samples)
• NDC 00641-6078-01 — Ondansetron injection 4 mg/2 mLAI (464 hospitals, 64,652–68,711 samples)
• NDC 00143-9924-90 — Cefazolin sodium injection 1 gramAI (900 hospitals, 57,585–68,376 samples)
• NDC 00409-8183-01 — Potassium acetate intravenous solutionAI (684 hospitals, 66,946–68,287 samples)
• NDC 63323-0873-10 — Dextrose and saline intravenous solutionAI (95 hospitals, 68,092–68,254 samples)
• NDC 00069-0248-10 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (372 hospitals, 65,665–68,248 samples)
• NDC 73293-0001-02 — Lidocaine 1% injection solutionAI (385 hospitals, 61,265–68,222 samples)
• NDC 00270-1315-98 — Iopamidol 300 mg/mL contrast injectionAI (107 hospitals, 67,284–68,211 samples)
• NDC 00409-1746-30 — Preservative-free bupivacaine with epinephrine injectionAI (635 hospitals, 65,193–68,190 samples)
• NDC 00407-1414-90 — Omnipaque 350 contrast injectionAI (285 hospitals, 67,007–68,024 samples)
• NDC 00409-4699-33 — Propofol 500 mg/50 mL intravenous emulsionAI (481 hospitals, 59,836–67,990 samples)
• NDC 00019-1333-16 — Ioversol 350 contrast injectionAI (92 hospitals, 66,754–67,969 samples)
• NDC 76329-3302-01 — 50% dextrose injectionAI (875 hospitals, 63,745–67,885 samples)
• NDC 25021-0700-01 — Ketorolac tromethamine 15 mg/mL injectionAI (395 hospitals, 63,076–67,774 samples)
• NDC 51754-5001-01 — Sodium bicarbonate 8.4% IV solutionAI (589 hospitals, 58,516–67,651 samples)
• NDC 00409-1660-20 — Dexmedetomidine IV solution in salineAI (261 hospitals, 65,880–67,599 samples)
• NDC 00409-6625-22 — Sodium bicarbonate 8.4% IV solutionAI (444 hospitals, 61,097–67,577 samples)
• NDC 00143-9787-10 — Enalaprilat injection, 1.25 mg/mLAI (705 hospitals, 65,159–67,409 samples)
• NDC 00074-4380-10 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (361 hospitals, 65,775–67,197 samples)
• NDC 23155-0549-31 — Ondansetron hydrochloride injection, 40 mgAI (505 hospitals, 58,955–67,073 samples)
• NDC 63323-0462-01 — Bupivacaine with epinephrine local anesthetic injectionAI (430 hospitals, 65,890–67,042 samples)
• NDC 00409-1159-10 — Bupivacaine 0.25% injection (preservative-free)AI (197 hospitals, 64,881–66,663 samples)
• NDC 63323-0426-12 — Rocuronium injection, 10 mg per mLAI (106 hospitals, 65,450–66,548 samples)
• NDC 00409-1283-31 — Hydromorphone injection, 1 mg/mLAI (926 hospitals, 46,488–66,360 samples)
• NDC 63323-0089-50 — Sodium bicarbonate 8.4% IV solutionAI (620 hospitals, 59,013–66,357 samples)
• NDC 25021-0826-82 — Zoledronic acid IV infusionAI (966 hospitals, 64,377–66,321 samples)
• NDC 00069-0248-01 — Propofol intravenous emulsion, various vial and syringe sizesAI (330 hospitals, 64,772–66,185 samples)